Lexicon Pharmaceuticals Inc (LXRX) stock saw a decline, ending the day at $0.69 which represents a decrease of $-0.02 or -2.82% from the prior close of $0.71. The stock opened at $0.72 and touched a ...
H.C. Wainwright has recently initiated Lexicon Pharmaceuticals Inc (LXRX) stock to Buy rating, as announced on June 17, 2024, according to Finviz. Earlier, on April 30, 2024, Leerink Partners had ...